News + Filings Transactions
|
Gujrathi Sheila
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | Janux Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 12.5k | $13.22 | $165.2k | | 06/14/2023 |
| 06/08/2023 | Ventyx Biosciences, Inc. | | Grant | Stock Option (right to buy) | 15.9k | $34.83 | $555.1k | | 06/08/2023 |
| 03/30/2023 | Ventyx Biosciences, Inc. | | Sale | Common Stock | 100k | $33.73 | $3.4M | | 03/30/2023 |
| 03/30/2023 | Ventyx Biosciences, Inc. | | Exercise | Stock Option (Right to Buy) | 100k | $6.03 | $603k | | 03/30/2023 |
| 06/14/2022 | Janux Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 12.5k | $10.73 | $134.1k | | 06/14/2022 |
| 06/09/2022 | Ventyx Biosciences, Inc. | | Grant | Stock Option (right to buy) | 13.3k | $16.54 | $220k | | 06/09/2022 |
| 12/02/2021 | Ventyx Biosciences, Inc. | | Grant | Stock Option (right to buy) | 277.9k | $18.65 | $5.2M | | 12/02/2021 |
| 10/25/2021 | Ventyx Biosciences, Inc. | | Conversion | Series A Preferred Stock | 32.9k | $0.00 | $0 | | 10/25/2021 |
| 10/25/2021 | Ventyx Biosciences, Inc. | | Conversion | Common Stock | 32.9k | $0.00 | $0 | | 10/25/2021 |
| 06/15/2020 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 8.5k | $65.39 | $555.8k | | 06/15/2020 |
| 02/14/2020 | Gossamer Bio, Inc. | GOSS | Grant | Common Stock | 189.5k | $0.00 | $0 | | 02/14/2020 |
| 02/14/2020 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (right to buy) | 292k | $14.55 | $4.2M | | 02/14/2020 |
| 09/27/2019 | Gossamer Bio, Inc. | GOSS | Purchase | Common Stock | 10k | $16.80 | $168k | By family trust | 09/27/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 15k | $27.06 | $405.9k | | 04/22/2019 |
| 03/25/2019 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (right to buy) | 380k | $22.10 | $8.4M | | 03/25/2019 |
| 02/12/2019 | Gossamer Bio, Inc. | GOSS | Conversion | Series B Preferred Stock | 56k | $0.00 | $0 | By family trust | 02/12/2019 |
| 02/12/2019 | Gossamer Bio, Inc. | GOSS | Conversion | Series A Preferred Stock | 223.2k | $0.00 | $0 | By family trust | 02/12/2019 |
| 02/12/2019 | Gossamer Bio, Inc. | GOSS | Conversion | Common Stock | 62k | $0.00 | $0 | By family trust | 02/12/2019 |
| 05/10/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $17.27 | $172.7k | | 05/10/2018 |
| 05/10/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $29.80 | $298k | | 05/10/2017 |
| 05/19/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $42.25 | $422.5k | | 05/19/2016 |
|